Analyst Chris Schott works at JPMORGAN and is focused on the Healthcare sector with 290 price targets and ratings documented since 2013 spanning on 19 stocks. Analyst's average stock valuation to be materialised ratio is 45.77% with an average time for price targets to be met of 229.05 days.
Most recent stock forecast was given on VTRS, at 15-Nov-2022.
Chris Schott best performing recommendations are on EQRX.
The best stock recommendation documented was for EQRX at 8/16/2022. The price target of $5 was fulfilled within 2 days with a profit of $0.17 (3.52%) receiving and performance score of 17.6.
Average potential price target upside